Skip to main content

Duke Cancer Institute

DCI Blog
Events
DCI Members
Contact
Give

Cancer Types

All Cancers
Primary Brain Cancer
Brain and Spine Metastasis
Breast Cancer
Endocrine Neoplasia
Gastrointestinal Cancer
Gynecologic Cancer
Head and Neck Cancer
Hematologic Malignancies and Cellular Therapy
Melanoma and Advanced Skin Cancers
Pediatric Cancers
Prostate and Urologic Cancers
Sarcoma
Thoracic Cancer

Cancer Therapies
Immunotherapy
Molecular Tumor Board

Supportive Care

Supportive Care and Survivorship Center

Research

Cancer Registry
Clinical Trials
Research Programs
Shared Resources

Education and Training

Office of Cancer Research Training and Education Coordination

About DCI

DCI Overview
DCI Members
Nursing
Careers
Community Outreach, Engagement, and Equity
Office of Equity, Diversity, and Inclusion
Contact
DCI blog
Events

Get Involved

Giving Opportunities
Benefits and Special Events
Breakthroughs Magazine

Make an Appointment

Blogs

New E-Cigarette Laws Could Drive Some to Smoke More

Updated

August 13, 2023

Written By

Samiha Khanna

Samiha Khanna

Duke Health News

Topics

Lung Cancer

Share

Share This Page

Print Page Or Copy Link Url

Copied to clipboard

Related News

News Mention

Pfizer Reports Positive Phase 2 Results for Ponsegromab in Cancer Cachexia Patients

September 17, 2024

Yahoo News

Graphic image showing lung nodules

News Mention

New Lung Nodule Clinic Expedites Early Lung Cancer Diagnosis

June 20, 2024

Clinical Practice Today

Featured DCI Members

F Joseph McClernon

F Joseph McClernon

F Joseph McClernon

Professor in Psychiatry and Behavioral Sciences

Related News

News Mention

Pfizer Reports Positive Phase 2 Results for Ponsegromab in Cancer Cachexia Patients

September 17, 2024

Yahoo News

Graphic image showing lung nodules

News Mention

New Lung Nodule Clinic Expedites Early Lung Cancer Diagnosis

June 20, 2024

Clinical Practice Today

Website Privacy Policy
Sitemap
Duke Health Anti-Racism Pledge
Notice on Nondiscrimination
Notice of Privacy Practices
Terms and Conditions
Accessibility
© DUKE CANCER INSTITUTE 2024

Back to Top